• Back to Haptoglobin (Hp)

• Adams JN, Cox AJ, Freedman BI, Langefeld CD, Carr JJ, Bowden DW. Genetic analysis of haptoglobin polymorphisms with cardiovascular disease and type 2 diabetes in the Diabetes Heart Study. Cardiovasc Diabetol. 2013;12:31
• Bhensdadia NM, Hunt KJ, Lopes-Virella MF, Michael Tucker J, Mataria MR, Alge JL, Neely BA, Janech MG, Arthur JM. Urine haptoglobin levels predict early renal functional decline in patients with type 2 diabetes. Kidney Int. 2013 Jun;83 (6):1136-43
• Cahill LE, Levy AP, Chiuve SE, Jensen MK, Wang H, Shara NM, Blum S, Howard BV, Pai JK, Mukamal KJ, Rexrode KM, Rimm EB. Haptoglobin genotype is a consistent marker of coronary heart disease risk among individuals with elevated glycosylated hemoglobin. J Am Coll Cardiol. 2013 Feb 19;61 (7):728-37
• Carter K, Worwood M. Haptoglobin: a review of the major allele frequencies worldwide and their association with diseases. Int J Lab Hematol. 2007 Apr;29 (2):92-110
• Chen YC, Lee CC, Huang CY, Huang HB, Yu CC, Ho YC, Su YC. Haptoglobin polymorphism as a risk factor for chronic kidney disease: a case-control study. Am J Nephrol. 2011;33 (6):510-4
• Costacou T, Levy AP. Haptoglobin genotype and its role in diabetic cardiovascular disease. J Cardiovasc Transl Res. 2012 Aug;5 (4):423-35
• Goldenstein H, Levy NS, Levy AP. Involvement of haptoglobin in prevention of oxidative stress cause by hemoglobin in preeclampsia. Adv Biosci Biotechnol. 2012;3:1037-1042
• Ko DH, Chang HE, Kim TS, Song EY, Park KU, Song J, Han KS. A review of haptoglobin typing methods for disease association study and preventing anaphylactic transfusion reaction. Biomed Res Int. 2013;2013:390630
• Leclerc JL, Blackburn S, Neal D, Mendez NV, Wharton JA, Waters MF, Dore S. Haptoglobin phenotype predicts the development of focal and global cerebral vasospasm and may influence outcomes after aneurysmal subarachnoid hemorrhage. Proc Natl Acad Sci U S A. 2015 Jan 27;112 (4):1155-60
• Levy AP, Asleh R, Blum S, Levy NS, Miller-Lotan R, Kalet-Litman S, Anbinder Y, Lache O, Nakhoul FM, Asaf R, Farbstein D, Pollak M, Soloveichik YZ, Strauss M, Alshiek J, Livshits A, Schwartz A, Awad H, Jad K, Goldenstein H. Haptoglobin: basic and clinical aspects. Antioxid Redox Signal. 2010 Feb;12 (2):293-304
• Levy NS, Levy AP. Changing the face of diabetic care with haptoglobin genotype selection and vitamin e. Rambam Maimonides Med J. 2011 Apr;2 (2):e0047
• Papp M, Foldi I, Nemes E, Udvardy M, Harsfalvi J, Altorjay I, Mate I, Dinya T, Varvolgyi C, Barta Z, Veres G, Lakatos PL, Tumpek J, Toth L, Szathmari E, Kapitany A, Gyetvai A, Korponay-Szabo IR. Haptoglobin polymorphism: a novel genetic risk factor for celiac disease development and its clinical manifestations. Clin Chem. 2008 Apr;54 (4):697-704
• Pirincci N, Gecit I, Gunes M, Kemik AS, Yuksel MB, Kaba M, Ceylan K, Aslan M. Haptoglobin levels in Turkish patients with bladder cancer and its association with clinicopathological features. Asian Pac J Cancer Prev. 2012;13 (12):6063-6
• Polticelli F, Bocedi A, Minervini G, Ascenzi P. Human haptoglobin structure and function--a molecular modelling study. FEBS J. 2008 Nov;275 (22):5648-56
• Pompach P, Novakova J, Kavan D, Benada O, Ruzicka V, Volny M, Novak P. Planar Functionalized Surfaces for Direct Immunoaffinity Desorption/Ionization Mass Spectrometry. Clin Chem. 2016 Jan;62 (1):270-8
• Speeckaert R, Brochez L, Lambert J, van Geel N, Speeckaert MM, Claeys L, Langlois M, Van Laer C, Peeters P, Delanghe JR. The haptoglobin phenotype influences the risk of cutaneous squamous cell carcinoma in kidney transplant patients. J Eur Acad Dermatol Venereol. 2012 May;26 (5):566-71
• Suzuki K, Yagi K, Oka R, Saiki Y, Kubota M, Sugihara M, Ito N, Kawashiri MA, Nohara A, Horita H, Takeda Y, Yamagishi M, Kobayashi J. Relationships of serum haptoglobin concentration with HbA1c and glycated albumin concentrations in Japanese type 2 diabetic patients. Clin Chem Lab Med. 2009;47 (1):70-4
• Weissgerber TL, Roberts JM, Jeyabalan A,